MTOR and neoplasm: However, our data support the concept that miR-100 may be responsible for inter-individual heterogeneity of mTOR expression in specific tumor types and even for the occurrence of dynamic changes of mTOR expression (and responsiveness to mTOR inhibitors) in individual patients.